Innovotech Inc. (TSXV:IOT)

Market Cap	9.80M +164.5%
Revenue (ttm)	4.53M +106.6%
Net Income	94.38K -58.0%
EPS	0.00 -62.8%
Shares Out	54.44M
PE Ratio	96.83
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,534
Average Volume	43,411
Open	0.1800
Previous Close	0.1750
Day's Range	0.1800 - 0.1800
52-Week Range	0.1000 - 0.3400
Beta	1.17
RSI	41.20
Earnings Date	Apr 24, 2026

About Innovotech

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; an...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Craig Milne
• Employees: 16
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: IOT

Financial Performance

In 2025, Innovotech's revenue was 4.53 million, an increase of 106.65% compared to the previous year's 2.19 million. Earnings were 94,375, a decrease of -58.01%.